Literature DB >> 29866893

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver.

Hemant Shah1, Marc Bilodeau2, Kelly W Burak2, Curtis Cooper2, Marina Klein2, Alnoor Ramji2, Dan Smyth2, Jordan J Feld2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29866893      PMCID： PMC5988519          DOI： 10.1503/cmaj.170453

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  85 in total

Review 1.  Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?

Authors:  Indra Neil Guha; Robert P Myers; Keyur Patel; Jayant A Talwalkar
Journal:  Hepatology       Date:  2011-08-09       Impact factor: 17.425

2.  Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.

Authors:  Stefan Zeuzem; Graham R Foster; Stanley Wang; Armen Asatryan; Edward Gane; Jordan J Feld; Tarik Asselah; Marc Bourlière; Peter J Ruane; Heiner Wedemeyer; Stanislas Pol; Robert Flisiak; Fred Poordad; Wan-Long Chuang; Catherine A Stedman; Steven Flamm; Paul Kwo; Gregory J Dore; Gladys Sepulveda-Arzola; Stuart K Roberts; Ruth Soto-Malave; Kelly Kaita; Massimo Puoti; John Vierling; Edward Tam; Hugo E Vargas; Rafi Bruck; Francisco Fuster; Seung-Woon Paik; Franco Felizarta; Jens Kort; Bo Fu; Ran Liu; Teresa I Ng; Tami Pilot-Matias; Chih-Wei Lin; Roger Trinh; Federico J Mensa
Journal:  N Engl J Med       Date:  2018-01-25       Impact factor: 91.245

3.  Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.

Authors:  Naveed Z Janjua; Mei Chong; Margot Kuo; Ryan Woods; Jason Wong; Eric M Yoshida; Morris Sherman; Zahid A Butt; Hasina Samji; Darrel Cook; Amanda Yu; Maria Alvarez; Mark Tyndall; Mel Krajden
Journal:  J Hepatol       Date:  2016-11-04       Impact factor: 25.083

4.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

5.  Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Sarah Maylin; Michelle Martinot-Peignoux; Rami Moucari; Nathalie Boyer; Marie-Pierre Ripault; Dominique Cazals-Hatem; Nathalie Giuily; Corinne Castelnau; Ana Carolina Cardoso; Tarik Asselah; Cyrille Féray; Marie Hélène Nicolas-Chanoine; Pierre Bedossa; Patrick Marcellin
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

6.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 7.  Burden of disease and cost of chronic hepatitis C infection in Canada.

Authors:  Robert P Myers; Mel Krajden; Marc Bilodeau; Kelly Kaita; Paul Marotta; Kevork Peltekian; Alnoor Ramji; Chris Estes; Homie Razavi; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

8.  Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

9.  Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.

Authors:  Shelly Bolotin; Jordan J Feld; Gary Garber; William W L Wong; Fiona M Guerra; Tony Mazzulli
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

10.  Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Authors:  Marc Bourlière; Stuart C Gordon; Steven L Flamm; Curtis L Cooper; Alnoor Ramji; Myron Tong; Natarajan Ravendhran; John M Vierling; Tram T Tran; Stephen Pianko; Meena B Bansal; Victor de Lédinghen; Robert H Hyland; Luisa M Stamm; Hadas Dvory-Sobol; Evguenia Svarovskaia; Jie Zhang; K C Huang; G Mani Subramanian; Diana M Brainard; John G McHutchison; Elizabeth C Verna; Peter Buggisch; Charles S Landis; Ziad H Younes; Michael P Curry; Simone I Strasser; Eugene R Schiff; K Rajender Reddy; Michael P Manns; Kris V Kowdley; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2017-06-01       Impact factor: 91.245
View more
  36 in total

1.  Should we screen people at increased risk of hepatitis C virus infection?

Authors: 
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

2. 

Authors: 
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

3.  Quick and painless: 2018 Updates on guideline recommendations.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

4.  Preventing vertical transmission of HCV in Canada.

Authors:  Chelsea Elwood; Laura J Sauve; Neora Pick
Journal:  CMAJ       Date:  2019-06-17       Impact factor: 8.262

5.  Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.

Authors:  M Eugenia Socías; Lianping Ti; Evan Wood; Ekaterina Nosova; Mark Hull; Kanna Hayashi; Kora Debeck; M-J Milloy
Journal:  Liver Int       Date:  2019-02-24       Impact factor: 5.828

6.  Rapid recommendations: Updates from 2020 guidelines: part 1.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

7. 

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

Review 8.  Hepatitis C models of care: approaches to elimination.

Authors:  Mia J Biondi; Jordan J Feld
Journal:  Can Liver J       Date:  2020-06-04

9.  Validating viral hepatitis B and C diagnosis codes: a retrospective analysis using Ontario's health administrative data.

Authors:  Abdool S Yasseen; Jeffrey C Kwong; Rafal Kustra; Laura Holder; Hannah Chung; Liane Macdonald; Naveed Z Janjua; Tony Mazzulli; Jordan Feld; Natasha S Crowcroft
Journal:  Can J Public Health       Date:  2021-01-08

10.  An outbreak of hepatitis C virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario.

Authors:  Arianne Folkema; Hsiu-Li Wang; Kristy Wright; M Mustafa Hirji; Anton Andonov; Kathryn Bromley; Chad Ludwig; Amy MacArthur
Journal:  Can Commun Dis Rep       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.